Clinical trial of the effect of breathing exercise on expiratory force and abdominal muscle in stroke patients

Not Applicable

• Conditions: Stroke; C10.228.140.300.775

• Registration Number: RBR-8w44f6
• Lead Sponsor: Hospital das Clínicas da Faculdade de Medicina de Botucatu - UNESP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-02
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients aged 18 years and under 80 years of age admitted to the stroke unit of the Clinical Hospital of the Botucatu Medical School, with clinical diagnosis of ischemic stroke by magnetic resonance or computed tomography with up to 80 years will be evaluated. 72 hours of the ictus, absence of disability prior to hospitalization with score less than or equal to 1 in eMR, item 1a (level of consciousness), 1c (Commands: open / close eyes, shake and release hand), language and facial paresis NIHSS less than equal to 1, no previous dementia or other associated neuromuscular diseases, no severe valvulopathy and previous major thoracic or abdominal surgery under 1 year, no congestive heart failure class III and IV, no asthma or decompensated chronic obstructive pulmonary disease (COPD) with a closed diagnosis.

Exclusion Criteria

Patients with previous complaints of dysphagia, clinical instability, invasive mechanical ventilation or palliative care will be excluded, those who fail to perform the MIP / MEP assessment protocol, ventilometry, non-adaptation to training, worsening of clinical and hemodynamic status and those who do not agree to participate in the study or refuse to continue the training.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome<br>The primary outcome to be evaluated is respiratory function through expiratory muscle strength, through a Support® brand manovacuometer (São Paulo, Brazil) with an operating range of ± 120 cmH2O, and maximum expiratory pressure (MEP) and inspiratory pressure were measured. maximum (MIP) within 72h.<br><br>

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes<br>The following secondary outcomes will be assessed: muscle electrical activity of the abdomen muscles, assessed by superficial electromyography; CV by the ventilometer; FPM; eMR functional disability; individual autonomy for self-care by IB; severity of neurological status by NIHSS; QOL by EUROQOL, sequentially on the first day and the fifth day after intervention.